Early, molecular detection of cancer utilizing circulating cell-free DNA assay with ultra high accuracy and sensitivity

Authors :: Helmy Eltoukhy
Chloe E. Atreya
Katharine Dilger
Stefanie Mortimer
Diana Abdueva
Darya Chudova
Pamela N. Munster
Jeeyun Lee
AmirAli Talasaz
Ankit Sarin
Jim Leng
Source :: Journal of Clinical Oncology. 34:11540-11540
Publication Year :: 2016
Publisher :: American Society of Clinical Oncology (ASCO), 2016.
Abstract: 11540Background: Analysis of cell-free circulating tumor DNA (ctDNA) by next-generation sequencing (NGS) is a promising method for early detection of cancer. Applications include screening high ris...

Subjects :: Cancer Research
Oncology
business.industry
Circulating tumor DNA
Cancer research
medicine
Cancer
Early detection
Sensitivity (control systems)
medicine.disease
business
Circulating Cell-Free DNA

Tools